Gene: CERCAM
Official Full Name: cerebral endothelial cell adhesion moleculeprovided by HGNC
Gene Summary: Enables identical protein binding activity. Acts upstream of or within cell adhesion. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22926 | CERCAM Knockout cell line (HeLa) | Human | CERCAM | 1:3~1:6 | Negative | Online Inquiry |
KO22927 | CERCAM Knockout cell line (HCT 116) | Human | CERCAM | 1:2~1:4 | Negative | Online Inquiry |
KO22928 | CERCAM Knockout cell line (HEK293) | Human | CERCAM | 1:3~1:6 | Negative | Online Inquiry |
KO22929 | CERCAM Knockout cell line (A549) | Human | CERCAM | 1:3~1:4 | Negative | Online Inquiry |
CERCAM Gene Knockout Cell Lines are genetically engineered cell lines designed to facilitate the study of gene function by eliminating the expression of specific target genes through the use of CRISPR/Cas9 technology. These cell lines provide researchers with a powerful tool for elucidating the biological roles of genes in various cellular contexts, offering insights into gene regulation, protein interactions, and disease mechanisms.
The primary function of CERCAM Gene Knockout Cell Lines lies in their ability to create precise gene deletions, thus allowing for the investigation of phenotypic changes that arise from the loss of gene function. By utilizing CRISPR/Cas9, these cell lines achieve efficient and specific targeting of the desired genomic loci, ensuring the integrity of surrounding genetic material is maintained. Researchers can use these knockout models to examine pathways involved in development, disease progression, and response to therapeutics.
The scientific importance of CERCAM Gene Knockout Cell Lines is evident in their widespread application in both basic research and clinical settings. These models are invaluable for studying cancer biology, neurodegenerative disorders, and metabolic diseases, enabling the identification of potential therapeutic targets and biomarkers. Furthermore, they facilitate high-throughput screening and validation of drug candidates, significantly advancing preclinical research.
Compared to traditional knockout strategies, CERCAM Gene Knockout Cell Lines offer several unique advantages, including reduced time and cost for generating knockout models, improved specificity and efficiency of gene editing, and a wide variety of cell types available to suit diverse experimental needs. This allows researchers to design experiments that are customized to their specific research questions while minimizing off-target effects.
For researchers and clinicians alike, the value of CERCAM Gene Knockout Cell Lines is profound. These models not only streamline experimental workflows but also enhance the reliability of results—ultimately accelerating the pace of discovery in the life sciences.
Our company is dedicated to delivering cutting-edge biological products, backed by a team of experts in gene editing technologies. With our comprehensive range of CERCAM Gene Knockout Cell Lines, we are committed to empowering the scientific community and driving forward innovative research capabilities.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.